| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CXCR3 | CXCR3 | mouse model | 27057462 | Details |  |  |  |  |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CCR5 | CCR5 | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CCR9 | CCR9 | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CCR10 | CCR10 | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | VLA-4 | ITGA4 | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD4+ T cells | CD4-CD28+ T cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD4+ T cells | CD4-CD28- T cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD4+ T cells | CD4+ T helper cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD4+ T cells | CD4+CD25+ regulatory T cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD4+ T cells | CD4+ cytotoxic T cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD4+ T cells | CD4+ T cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD8+ T cells | Naive CD8+ T cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD8+ T cells | Effector CD8+ memory T (Tem) cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD8+ T cells | Exhausted CD8+ T cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD8+ T cells | CD8+ T cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | CD8+ T cells | CD8+ cytotoxic T cell | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | TLR-5 | TLR5 | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | IVAG E6/E7 co-administered with flagellin | TLR-6 | TLR6 | mouse model | 27057462 | Details | | | | |
| Cervical Cancer | CESC | SFVeE6/E7 | CD8+ CD103+ T cells | CD8+ T cell | mouse model | 28932636 | Details | | | | |
| Cervical Cancer | CESC | SFVeE6/E7 | CD8+ CD103+ T cells | CD8+ T cell | mouse model | 28932636 | Details | | | | |
| Cervical Cancer | CESC | NP-MN | lgG | NA | Mouse model | 29551594 | Details | | | | |
| Cervical Cancer | CESC | NP-MN | TC-1 specific cells | NA | Mouse model | 29551594 | Details | | | | |
| Cervical Cancer | CESC | NP-MN | IFN-γ | IFNG | Mouse model | 29551594 | Details | | | | |